ATAI Life Sciences B.V./ NL0015000DX5 /
| 2024-04-16 6:40:20 PM | Chg. +0.09 | Volume | Bid6:42:20 PM | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 2.17USD | +4.34% | 36,492 Turnover: 76,076.49 |
2.16Bid Size: 600 | -Ask Size: - | 2.18 | 2.05 |
GlobeNewswire
03-28
atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporat...
GlobeNewswire
03-27
atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Stu...
GlobeNewswire
03-11
IntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life Sciences
GlobeNewswire
03-04
atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
GlobeNewswire
02-28
atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
GlobeNewswire
01-04
atai Life Sciences Announces Strategic Investment in Beckley Psytech to Accelerate the Clinical Deve...
GlobeNewswire
01-02
atai Life Sciences Announces Positive Topline Results from Single Ascending Dose Phase 1 Study with ...
GlobeNewswire
2023-12-05
IntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With a...
Newsfile Corp
2023-11-28
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with ...
GlobeNewswire
2023-11-14
atai Life Sciences Reports Third Quarter 2023 Financial Results and Pipeline Highlights
GlobeNewswire
2023-10-06
atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit
GlobeNewswire
2023-10-02
atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants
GlobeNewswire
2023-09-06
atai Life Sciences to Participate in Upcoming September Investor Conferences
GlobeNewswire
2023-08-31
IntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partne...
